Quyen Duong Email

Scientist I, Bioanalysis & Pharmacokinetics . Acceleron Pharma

Current Roles

Employees:
86
Revenue:
$17.3M
About
Acceleron is a Cambridge-based, clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. The Company's leadership in the understanding of TGF-beta biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair. Acceleron focuses its research and development efforts in hematologic, neuromuscular, and pulmonary diseases. In hematology, the Company and its global collaboration partner, Celgene, are developing luspatercept for the treatment of chronic anemia in myelodysplastic syndromes, beta-thalassemia, and myelofibrosis. Acceleron is also advancing its neuromuscular franchise with two distinct Myostatin+ agents, ACE-083 and ACE-2494, and a Phase 2 pulmonary program with sotatercept in pulmonary arterial hypertension.
Acceleron Pharma Address
128 Sidney Street
Cambridge, MA
United States
Acceleron Pharma Email

Past Companies

Acceleron PharmaScientist I, Bioanalysis & Pharmacokinetics
Acceleron PharmaStaff Research Associate, Bioanalytical Development
BiogenSenior Associate Scientist

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.